OncoTAb
Location: United States, office address not availableoncotab.com
OncoTAb is developing tMUC1-targeted therapies for pancreatic cancer, including a radiotheranostic and MUCD3, a bispecific T-cell engager.
Founders and contacts
- FoundersBeing confirmed, locked
- Founder emailsBeing confirmed, locked
- LinkedInCompany page, locked
Explore
More startups in United States
Are you a founder of OncoTAb and want your details removed? Write to us and we remove them within 72 hours.